LRINEC Score for Necrotizing Soft Tissue Infection

Why use it

Necrotizing fasciitis is a surgical emergency with mortality rates of 20–40% even with aggressive management — and mortality approaches 100% without urgent surgical debridement. The clinical features of early NF may be indistinguishable from severe cellulitis, making timely diagnosis challenging. The LRINEC score provides an objective, laboratory-based adjunct to clinical assessment that can help identify high-risk patients who should undergo urgent surgical exploration, even before frank tissue necrosis is clinically apparent.

About

The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was developed by Wong and colleagues and published in Critical Care Medicine in 2004. It is a validated scoring system that uses six routine laboratory parameters to distinguish necrotizing soft tissue infections (NSTIs) — including necrotizing fasciitis — from other severe soft tissue infections (cellulitis, abscess) that are managed non-operatively. The six variables are: C-reactive protein (CRP), white blood cell count (WBC), hemoglobin, serum sodium, serum creatinine, and serum glucose. Each variable is assigned weighted points based on the degree of abnormality, generating a total score from 0 to 13. A score ≥6 raises concern for necrotizing fasciitis, and a score ≥8 is associated with a high risk of NF (sensitivity 89.9%, specificity 94.6% in the original derivation cohort). The LRINEC score was derived from a retrospective cohort of 314 patients in Singapore and has since been validated and studied in multiple international cohorts, though with variable performance.

When to use

• Any patient with a severe soft tissue infection (cellulitis, fasciitis) who may have early necrotizing fasciitis
• When clinical presentation is ambiguous — severe pain out of proportion to skin findings, skin discoloration, rapid progression
• Adjunct to CT/MRI imaging in intermediate-risk patients
• Determining urgency for surgical consultation — does this patient need the operating room now?
• Patients with risk factors for NF: diabetes, obesity, immunosuppression, peripheral vascular disease, IV drug use, recent trauma/surgery

Formula

Pearls & pitfalls

• A low LRINEC score does NOT exclude necrotizing fasciitis — the score has a sensitivity of approximately 80% and should not be used to rule out NF in high clinical suspicion cases.
• The clinical signs of NF may be minimal early in the disease — severe pain disproportionate to skin findings, rapid progression, systemic toxicity, and skin bullae/ecchymosis are alarming features regardless of LRINEC score.
• CT imaging showing gas tracking along fascial planes, fascial thickening, or fluid collections is highly specific for NF — CT is the imaging modality of choice when NF is suspected and the patient is stable enough for imaging.
• Surgical exploration (the "finger test") is the gold standard for diagnosis — if NF is strongly suspected clinically, do NOT delay surgery for laboratory or imaging results.
• CRP is the single most weighted variable in the LRINEC score — CRP >150 mg/L contributes 4 points (the maximum for any single variable). Markedly elevated CRP in a soft tissue infection is a serious red flag.
• Hyponatremia is a consistent laboratory feature of severe NF — sodium <135 mEq/L in a patient with a skin infection should raise immediate suspicion.
• Type I NF (polymicrobial — aerobic + anaerobic) is more common in elderly, immunosuppressed, and diabetic patients. Type II NF (monomicrobial — usually Group A Streptococcus) can occur in healthy young adults.
• Clindamycin should be added to broad-spectrum antibiotics in suspected Streptococcal or Clostridial NF to suppress toxin production (protein synthesis inhibitor effect).
• Antibiotic coverage alone is never definitive treatment for NF — only source control (surgical debridement) is curative.
• LRINEC validation studies have shown variable sensitivity (59–89%) — the score performs better as a risk stratifier than a diagnostic test.

Next steps

LRINEC <6 (Low Risk): NF less likely. Close monitoring. Serial clinical reassessment. Repeat labs if no improvement in 12–24h. LRINEC 6–7 (Moderate Risk): Moderate suspicion for NF. Urgent surgical consultation. Consider CT imaging (free air, fascial thickening, fluid tracking along fascial planes). Lower threshold for surgical exploration. LRINEC ≥8 (High Risk): High suspicion for NF. Surgical consultation immediately. Do NOT wait for imaging if patient is deteriorating. Broad-spectrum IV antibiotics immediately (cover Gram-positives, Gram-negatives, and anaerobes — e.g., piperacillin-tazobactam + vancomycin ± clindamycin for toxin suppression). Prepare for urgent surgical debridement.

Evidence

Wong CH et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-1541. PMID:15241098. Derivation cohort: 314 patients. Score ≥8: sensitivity 89.9%, specificity 94.6%, PPV 93.4%, NPV 91.7%. Multiple validation studies showed variable performance (sensitivity 59–90%, specificity 60–94%), emphasizing that clinical judgment must complement the score.

References

1. Wong CH et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score. Crit Care Med. 2004;32(7):1535-1541. — link
2. Fernando SM et al. Necrotizing soft tissue infection: diagnostic accuracy of physical examination alone, computer tomography, and LRINEC score: systematic review and meta-analysis. Ann Surg. 2019;269(1):58-65. — link
3. Bechar J et al. Laboratory risk indicator for necrotizing fasciitis (LRINEC) score for the assessment of early necrotizing fasciitis: a systematic review of the literature. ANZ J Surg. 2017;87(4):E83-E87. — link